Market Cap: $59.67M
II
Inovio Pharmaceuticals, Inc.
INO
NASDAQ (NASDAQ Global Select)USD
Market Cap: $59.67M
Inovio Pharmaceuticals is achieving significant advancements through its partnership with ApolloBio in the development of VGX-3100, an investigational DNA immunotherapy aimed at treating cervical dysp…
Inovio Pharmaceuticals (Ticker: INO) focuses on the advancement of its lead candidate, INO-3107, which is currently undergoing a crucial review process by the U.S. FDA. With a Prescription Drug User F…
Inovio Pharmaceuticals actively engages in scientific discourse and innovation through its upcoming presentations at two prestigious conferences, underlining its commitment to advancing DNA medicine.…
Legal Challenges Loom Over Inovio Pharmaceuticals' Future Inovio Pharmaceuticals, Inc., a prominent player in the biotechnology sector focusing on DNA medicines for HPV-related diseases, cancer, and i…
Inovio Pharmaceuticals Faces Class Action Suit Over Alleged Misleading Statements Inovio Pharmaceuticals, Inc. is currently embroiled in a class action lawsuit alleging violations of federal securitie…
Inovio Pharmaceuticals Faces Class Action Lawsuits Over Alleged Misrepresentation Inovio Pharmaceuticals, Inc. is currently at the center of multiple class action lawsuits stemming from claims of secu…
Navigating Legal Waters: Inovio Pharmaceuticals Faces Class Action Lawsuits Inovio Pharmaceuticals finds itself at the center of multiple class action lawsuits following allegations of securities frau…
Inovio Pharmaceuticals Faces Legal Scrutiny Over Alleged SEC Violations Inovio Pharmaceuticals, Inc. is currently embroiled in a legal investigation due to allegations of violations of federal securit…
Inovio Pharmaceuticals Faces Legal Scrutiny Amid Allegations of Misleading Statements Inovio Pharmaceuticals, Inc. is currently under investigation for potential violations of federal securities laws,…
Inovio Pharmaceuticals Advances DNA Medicine Amid Positive Q4 Results Inovio Pharmaceuticals Inc showcases its operational resilience with its recent fourth-quarter performance that surpasses Wall Str…
Inovio Pharmaceuticals Faces Class Action Lawsuits Amid Allegations of Misleading Statements Inovio Pharmaceuticals, a biotechnology firm specializing in DNA medicines for diseases linked to the human…
Inovio Pharmaceuticals Faces Investor Scrutiny Amid Class Action Lawsuit Inovio Pharmaceuticals Inc. grapples with mounting legal challenges as allegations of securities fraud come to light. The Law O…
Inovio Pharmaceuticals Faces Class Action Lawsuit Amid Allegations of Misleading Statements Inovio Pharmaceuticals, Inc. is currently grappling with potential legal troubles as The Gross Law Firm reac…
Inovio Pharmaceuticals Prepares for Key Conference Presentations on Innovative Therapies Inovio Pharmaceuticals (NASDAQ: INO), a leading biotechnology firm specializing in DNA medicines for various he…
Inovio Pharmaceuticals Advances DNA Medicine for HPV-Related Conditions and COVID-19 Inovio Pharmaceuticals, a pioneering player in biotechnology specializing in DNA medicine, engages the scientific c…
Inovio Pharmaceuticals Faces Class Action Lawsuit Over Alleged Securities Violations On March 5, 2026, Pomerantz LLP introduces a class action lawsuit against Inovio Pharmaceuticals, Inc. in the Unite…
Innovative Collaboration Targets Aggressive Brain Cancer Treatment In a significant development for cancer therapy, INOVIO Pharmaceuticals has partnered with Akeso, Inc. to explore a new treatment for…
Inovio Pharmaceuticals Faces Class Action Over Misleading Statements Regarding INO-3107 Inovio Pharmaceuticals, Inc. is reportedly under scrutiny following the announcement of potential class action l…
Inovio Pharmaceuticals Contends with Legal Repercussions Following SEC Allegations Inovio Pharmaceuticals, Inc. is currently faced with multiple class action lawsuits stemming from allegations of secu…
Inovio Pharmaceuticals Faces Legal Challenges over Securities Allegations Inovio Pharmaceuticals, a biotechnology company focused on developing DNA medicines, experiences significant legal pressure as…
### Inovio Pharmaceuticals Faces Securities Fraud Class Actions Amid Regulatory Challenges Inovio Pharmaceuticals, Inc. is currently embroiled in multiple class action lawsuits alleging securities fra…
Legal Challenges Loom for Inovio Pharmaceuticals Amid Allegations of Misleading Disclosures Inovio Pharmaceuticals, Inc. faces significant legal scrutiny following a recent class action lawsuit filed…
Inovio Pharmaceuticals Faces Legal Scrutiny Over Alleged Misleading Statements Inovio Pharmaceuticals, Inc. is currently under scrutiny as The Gross Law Firm has issued a notice encouraging shareholde…
### Legal Challenges Loom for Inovio Pharmaceuticals Amid Allegations of Misleading Statements Inovio Pharmaceuticals, Inc. faces growing legal scrutiny as several law firms announce class action laws…
Inovio Pharmaceuticals Faces Class Action Lawsuits Over Misleading Statements Inovio Pharmaceuticals, Inc. is embroiled in legal challenges as shareholders initiate class action lawsuits alleging viol…